LPCAT1 and cancer: Lpcat1 modulation can play an important role in cancer pathogenesis and progression [25, 26] and we found this enzyme also significantly upregulated in the mAITL and hAITL neoplastic Tfh cells which suggest that Lpcat1 inhibition might also be a possible novel treatment option.